Coronavirus disease 2019 (COVID-19) as a potential trigger for benign recurrent intrahepatic cholestasis
- PMID: 35310310
- PMCID: PMC8908081
- DOI: 10.1002/ccr3.5557
Coronavirus disease 2019 (COVID-19) as a potential trigger for benign recurrent intrahepatic cholestasis
Abstract
Benign recurrent intrahepatic cholestasis (BRIC) is a rare disease characterized by recurrent severe itching and jaundice. Coronavirus disease 2019 (COVID-19) is a multisystemic acute viral disease and the liver is frequently affected. Here, we wanted to present a BRIC case triggered by COVID-19 infection, discussing it together with current information.
Keywords: benign recurrent intrahepatic cholestasis; coronavirus disease 2019; liver.
© 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Summerskill WHJ, Walshe JM. Benign recurrent intrahepatic obstructive cholestasis. Lancet. 1959;2:686‐690. - PubMed
-
- Ermis F, Oncu K, Ozel M, et al. Benign recurrent intrahepatic cholestasis: late initial diagnosis in adulthood. Ann Hepatol. 2010;2:207‐210. - PubMed
-
- van Ooteghem NA, Klomp LW, van Berge‐Henegouwen GP, Houwen RH. Benign recurrent intrahepatic cholestasis progressing to progressive familial intrahepatic cholestasis: low GGT cholestasis is a clinical continuum. J Hepatol. 2002;36:439‐443. - PubMed
-
- Klomp LWJ, Bull LN, Juijn JA, et al. Characterization of multiple different mutations in FIC1 assosicated with hereditary cholestasis. Hepatology. 1999;30:407A.
-
- Tygstrup N, Jensen B. Intermittent intrahepatic cholestasis of unknown etiology in five young males from the Faroe Islands. Acta Med Scand. 1969;185:523‐530. - PubMed
Publication types
LinkOut - more resources
Full Text Sources